# E-DRUG: Drug Regulation

**URL:** https://talk.edrugplus.org/t/e-drug-drug-regulation/147
**Category:** e-drug
**Created:** [June 14, 1996, 2:41pm UTC](https://talk.edrugplus.org/t/e-drug-drug-regulation/147 "1996-06-14T14:41:03Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![n.kiatying-angsulee](https://avatars.discourse-cdn.com/v4/letter/n/47e85d/32.png) [@n.kiatying-angsulee](https://talk.edrugplus.org/u/n.kiatying-angsulee)
#### Post date: [June 14, 1996, 2:41pm UTC](https://talk.edrugplus.org/t/e-drug-drug-regulation/147/1 "1996-06-14T14:41:03Z")

</div>

> Dear Friends,
> 
> Although the topic of problem drugs are of great concern globally ,  
> there are not many published research papers dealing with  
> pharmaceutical regulatory/registration system and policy.  
> Many papers came from consumer group trying to state the situation  
> of problem drugs and unethical marketing. Some papers also described  
> the system used in various countries.
> 
> Some interesting issues raised and/or studied are  
> 1. The efficiency/ effectiveness of regulatory system and how to assess  
> 2. The impact of regulatory action/de-registration on availability of  
> drug, on rational use, on research and development of drug.  
> 3. Factors influencing drug regulatory policies
> 
> Does anyone have the information about research in this area of  
> to share with. Any comment or suggestion on research issues  
> dealing with this area is greatly appreciated.
> 
> Many thanks and best regards,
> 
> Niyada  
> NIYADA KIATYING-ANGSULEE  
> HEALTH POLICY UNIT,  
> LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE  
> LONDON, WC1E 7HT, UK  
> TEL. +44-(0)171-9272311  
> FAX. +44-(0)171-6375391

[This is an interesting topic that is seriously neglected particularly in  
evaluating the effects of regulatory changes. There is a recent article in  
social science and Medicine by Hilbran Haak and Mariam Claeson on the  
banning of anti-diarrheal drugs.

Moderator Richard Laing]\>